🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/04/1992 | 24,01 | 24,03 | 23,46 | 23,68 | -1,57% | 2,40% | 8.660.462 |
| 15/04/1992 | 24,69 | 24,69 | 23,84 | 24,05 | -2,58% | 3,46% | 7.298.482 |
| 14/04/1992 | 24,45 | 24,77 | 24,35 | 24,69 | +1,31% | 1,71% | 5.210.237 |
| 13/04/1992 | 24,17 | 24,45 | 24,01 | 24,37 | +0,57% | 1,81% | 4.910.299 |
| 10/04/1992 | 24,15 | 24,29 | 23,99 | 24,23 | +1,50% | 1,23% | 4.625.453 |
| 09/04/1992 | 23,38 | 23,95 | 23,30 | 23,87 | +2,47% | 2,81% | 5.913.864 |
| 08/04/1992 | 23,24 | 23,32 | 23,06 | 23,30 | -0,09% | 1,11% | 7.219.253 |
| 07/04/1992 | 23,80 | 23,84 | 23,30 | 23,32 | -1,84% | 2,26% | 3.023.270 |
| 06/04/1992 | 23,66 | 23,87 | 23,64 | 23,76 | +1,01% | 1,01% | 3.658.987 |
| 03/04/1992 | 23,32 | 23,78 | 23,30 | 23,52 | +0,42% | 2,05% | 4.235.597 |
| 02/04/1992 | 23,78 | 23,86 | 23,28 | 23,42 | -1,59% | 2,42% | 5.056.181 |
| 01/04/1992 | 23,40 | 23,82 | 23,30 | 23,80 | +1,70% | 2,21% | 5.377.498 |
| 31/03/1992 | 23,38 | 23,68 | 23,38 | 23,40 | +0,08% | 1,28% | 3.538.258 |
| 30/03/1992 | 23,14 | 23,54 | 23,12 | 23,38 | +0,77% | 1,80% | 3.559.008 |
| 27/03/1992 | 23,46 | 23,48 | 23,10 | 23,20 | -1,44% | 1,61% | 5.392.589 |
| 26/03/1992 | 23,87 | 23,89 | 23,50 | 23,54 | -1,33% | 1,67% | 3.335.784 |
| 25/03/1992 | 23,93 | 24,07 | 23,82 | 23,86 | +0,00% | 1,08% | 4.551.254 |
| 24/03/1992 | 23,54 | 23,89 | 23,42 | 23,86 | +1,87% | 2,03% | 4.421.093 |
| 23/03/1992 | 23,40 | 23,48 | 23,22 | 23,42 | +0,09% | 1,10% | 3.749.534 |
| 20/03/1992 | 23,56 | 23,60 | 23,24 | 23,40 | -0,76% | 1,52% | 7.965.010 |
| 19/03/1992 | 23,66 | 23,68 | 23,50 | 23,58 | +0,17% | 0,76% | 2.943.413 |
| 18/03/1992 | 23,80 | 23,89 | 23,54 | 23,54 | -1,17% | 1,50% | 3.493.613 |
| 17/03/1992 | 23,48 | 23,84 | 23,48 | 23,82 | +1,53% | 1,52% | 3.963.326 |
| 16/03/1992 | 23,48 | 23,50 | 23,22 | 23,46 | -0,17% | 1,19% | 4.264.522 |
| 13/03/1992 | 23,66 | 23,70 | 23,22 | 23,50 | +0,17% | 2,02% | 5.477.477 |
| 12/03/1992 | 23,87 | 23,91 | 23,34 | 23,46 | -1,91% | 2,41% | 6.167.899 |
| 11/03/1992 | 24,09 | 24,15 | 23,86 | 23,91 | -1,15% | 1,24% | 3.617.486 |
| 10/03/1992 | 24,07 | 24,33 | 24,07 | 24,19 | +0,50% | 1,07% | 4.820.381 |
| 09/03/1992 | 23,89 | 24,17 | 23,89 | 24,07 | +0,92% | 1,16% | 4.049.472 |
| 06/03/1992 | 24,07 | 24,21 | 23,78 | 23,86 | -0,83% | 1,82% | 5.312.731 |